PPARA and metabolic dysfunction-associated steatotic liver disease: PPAR signaling regulates key processes such as adipogenesis, insulin resistance, and inflammation, which are central to NAFLD pathogenesis, and has been implicated in metabolic syndrome in previous GWASs of the Taiwanese population [34, 35].